BioCryst Pharmaceuticals Inc.
[WKN: 896047 | ISIN: US09058V1035]
5,758€ 1,30%
Echtzeit-Aktienkurs BioCryst Pharmaceuticals Inc.
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

BioCryst to Host R&D Day on November 3

RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the…